These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27876894)

  • 1. DDIT4 regulates mesenchymal stem cell fate by mediating between HIF1α and mTOR signalling.
    Gharibi B; Ghuman M; Hughes FJ
    Sci Rep; 2016 Nov; 6():36889. PubMed ID: 27876894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DDIT4 and Associated lncDDIT4 Modulate Th17 Differentiation through the DDIT4/TSC/mTOR Pathway.
    Zhang F; Liu G; Li D; Wei C; Hao J
    J Immunol; 2018 Mar; 200(5):1618-1626. PubMed ID: 29378913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Pathway for Hypoxia-Induced Proliferation and Migration in Human Mesenchymal Stem Cells: Involvement of HIF-1α, FASN, and mTORC1.
    Lee HJ; Ryu JM; Jung YH; Oh SY; Lee SJ; Han HJ
    Stem Cells; 2015 Jul; 33(7):2182-95. PubMed ID: 25825864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased SCF/c-kit by hypoxia promotes autophagy of human placental chorionic plate-derived mesenchymal stem cells via regulating the phosphorylation of mTOR.
    Lee Y; Jung J; Cho KJ; Lee SK; Park JW; Oh IH; Kim GJ
    J Cell Biochem; 2013 Jan; 114(1):79-88. PubMed ID: 22833529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Akt/mTOR attenuates age-related changes in mesenchymal stem cells.
    Gharibi B; Farzadi S; Ghuman M; Hughes FJ
    Stem Cells; 2014 Aug; 32(8):2256-66. PubMed ID: 24659476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PML nuclear bodies contribute to the basal expression of the mTOR inhibitor DDIT4.
    Salsman J; Stathakis A; Parker E; Chung D; Anthes LE; Koskowich KL; Lahsaee S; Gaston D; Kukurba KR; Smith KS; Chute IC; Léger D; Frost LD; Montgomery SB; Lewis SM; Eskiw C; Dellaire G
    Sci Rep; 2017 Mar; 7():45038. PubMed ID: 28332630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of hypoxia-inducible factor-1α, regulated in development and DNA damage response-1 and mammalian target of rapamycin in human placental BeWo cells under hypoxia.
    Zhou F; Guan LB; Yu P; Wang XD; Hu YY
    Placenta; 2016 Sep; 45():24-31. PubMed ID: 27577706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage-inducible transcript 4 (DDIT4) mediates methamphetamine-induced autophagy and apoptosis through mTOR signaling pathway in cardiomyocytes.
    Chen R; Wang B; Chen L; Cai D; Li B; Chen C; Huang E; Liu C; Lin Z; Xie WB; Wang H
    Toxicol Appl Pharmacol; 2016 Mar; 295():1-11. PubMed ID: 26825372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mTOR and PP2A Pathways Regulate PHD2 Phosphorylation to Fine-Tune HIF1α Levels and Colorectal Cancer Cell Survival under Hypoxia.
    Di Conza G; Trusso Cafarello S; Loroch S; Mennerich D; Deschoemaeker S; Di Matteo M; Ehling M; Gevaert K; Prenen H; Zahedi RP; Sickmann A; Kietzmann T; Moretti F; Mazzone M
    Cell Rep; 2017 Feb; 18(7):1699-1712. PubMed ID: 28199842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies.
    Pinto JA; Rolfo C; Raez LE; Prado A; Araujo JM; Bravo L; Fajardo W; Morante ZD; Aguilar A; Neciosup SP; Mas LA; Bretel D; Balko JM; Gomez HL
    Sci Rep; 2017 May; 7(1):1526. PubMed ID: 28484222
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Canales J; Valenzuela M; Bravo J; Cerda-Opazo P; Jorquera C; Toledo H; Bravo D; Quest AF
    Front Cell Infect Microbiol; 2017; 7():92. PubMed ID: 28401064
    [No Abstract]   [Full Text] [Related]  

  • 12. mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells.
    Matsumoto K; Arao T; Tanaka K; Kaneda H; Kudo K; Fujita Y; Tamura D; Aomatsu K; Tamura T; Yamada Y; Saijo N; Nishio K
    Cancer Res; 2009 Sep; 69(18):7160-4. PubMed ID: 19738050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIP4 transcriptionally activates DDIT4 and subsequent mTOR signaling to promote glioma progression.
    Li W; Hu S; Tian C; Wan X; Yu W; Guo P; Zhao F; Hua C; Lu X; Xue G; Han S; Guo W; Wang D; Deng W
    Free Radic Biol Med; 2021 Dec; 177():31-47. PubMed ID: 34648907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia inhibits mesenchymal stem cell proliferation through HIF1α-dependent regulation of P27.
    Kumar S; Vaidya M
    Mol Cell Biochem; 2016 Apr; 415(1-2):29-38. PubMed ID: 26920732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SCL/TAL1 Transcription Factor Represses the Stress Protein DDiT4/REDD1 in Human Hematopoietic Stem/Progenitor Cells.
    Benyoucef A; Calvo J; Renou L; Arcangeli ML; van den Heuvel A; Amsellem S; Mehrpour M; Larghero J; Soler E; Naguibneva I; Pflumio F
    Stem Cells; 2015 Jul; 33(7):2268-79. PubMed ID: 25858676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of autophagy and mTOR signaling in neural differentiation of bone marrow mesenchymal stem cells.
    Li Y; Wang C; Zhang G; Wang X; Duan R; Gao H; Peng T; Teng J; Jia Y
    Cell Biol Int; 2014 Nov; 38(11):1337-43. PubMed ID: 24890505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic roles of p53 and HIF1α in human renal cell carcinoma-cell apoptosis responding to the inhibition of mTOR and MDM2 signaling pathways.
    Liu QJ; Shen HL; Lin J; Xu XH; Ji ZG; Han X; Shang DH; Yang PQ
    Drug Des Devel Ther; 2016; 10():745-55. PubMed ID: 26937175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo inhibition of mTOR by 1,25-dihydroxyvitamin D
    Wang H; Wang J; Qu H; Wei H; Ji B; Yang Z; Wu J; He Q; Luo Y; Liu D; Duan Y; Liu F; Deng H
    Endocrine; 2016 Nov; 54(2):348-359. PubMed ID: 27395420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-γ orchestrates mesenchymal stem cell plasticity through the signal transducer and activator of transcription 1 and 3 and mammalian target of rapamycin pathways.
    Vigo T; Procaccini C; Ferrara G; Baranzini S; Oksenberg JR; Matarese G; Diaspro A; Kerlero de Rosbo N; Uccelli A
    J Allergy Clin Immunol; 2017 May; 139(5):1667-1676. PubMed ID: 27670240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells promote colorectal cancer progression through AMPK/mTOR-mediated NF-κB activation.
    Wu XB; Liu Y; Wang GH; Xu X; Cai Y; Wang HY; Li YQ; Meng HF; Dai F; Jin JD
    Sci Rep; 2016 Feb; 6():21420. PubMed ID: 26892992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.